Khalili S - Search Results

1

Epidemiology of COVID-19 in Tehran, Iran: A Cohort Study of Clinical Profile, Risk Factors, and Outcomes.

Hatamabadi H, Sabaghian T, Sadeghi A, Heidari K, Safavi-Naini SAA, Looha MA, Taraghikhah N, Khalili S, Karrabi K, Saffarian A, Shahsavan S, Majlesi H, Allahgholipour Komleh A, Hatari S, Zameni N, Ilkhani S, Hajimirzaei SM, Ghaffari A, Fallah MM, Kalantar R, Naderi N, Bahmaei P, Asadimanesh N, Esbati R, Yazdani O, Shojaeian F, Azizan Z, Ebrahimi N, Jafarzade F, Soheili A, Gholampoor F, Namazi N, Solhpour A, Jamialahamdi T, Pourhoseingholi MA, Sahebkar A. Hatamabadi H, et al. Among authors: khalili s. Biomed Res Int. 2022 May 10;2022:2350063. doi: 10.1155/2022/2350063. eCollection 2022. Biomed Res Int. 2022. PMID: 35592525 Free PMC article.

2

Well-controlled vs poorly-controlled diabetes in patients with COVID-19: Are there any differences in outcomes and imaging findings?

Raoufi M, Khalili S, Mansouri M, Mahdavi A, Khalili N. Raoufi M, et al. Among authors: khalili s, khalili n. Diabetes Res Clin Pract. 2020 Aug;166:108286. doi: 10.1016/j.diabres.2020.108286. Epub 2020 Jun 25. Diabetes Res Clin Pract. 2020. PMID: 32592836 Free PMC article. Clinical Trial.

3

Prevalence, Risk Factors and Outcomes Associated with Acute Kidney Injury in Patients Hospitalized for COVID-19: A Comparative Study between Diabetic and Nondiabetic Patients.

Khalili S, Sabaghian T, Sedaghat M, Soroureddin Z, Askari E, Khalili N. Khalili S, et al. Among authors: khalili n. J Diabetes Res. 2021 Jan 6;2021:6666086. doi: 10.1155/2021/6666086. eCollection 2021. J Diabetes Res. 2021. PMID: 33506050 Free PMC article.

4

A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19.

Kharazmi AB, Moradi O, Haghighi M, Kouchek M, Manafi-Rasi A, Raoufi M, Shoaei SD, Hadavand F, Nabavi M, Miri MM, Salarian S, Shojaei S, Khalili S, Sistanizad M, Sadeghi S, Karagah A, Asgari S, Jaffaraghaei M, Araghi S. Kharazmi AB, et al. Among authors: khalili s. Immun Inflamm Dis. 2022 Feb;10(2):201-208. doi: 10.1002/iid3.563. Epub 2021 Nov 11. Immun Inflamm Dis. 2022. PMID: 34762351 Free PMC article. Clinical Trial.

5

Acute Kidney Injury Outcome in COVID-19 Patients.

Sabaghian T, Ahmadi Koomleh A, Nassiri AA, Kharazmi AB, Khalili S. Sabaghian T, et al. Among authors: khalili s. Iran J Kidney Dis. 2022 Jan;1(1):44-51. Iran J Kidney Dis. 2022. PMID: 35271499 Free article.

6

Metabolic health's central role in chronic kidney disease progression: a 20-year study of obesity-metabolic phenotype transitions.

Khalili S, Safavi-Naini SAA, Zarand P, Masoumi S, Farsi Y, Hosseinpanah F, Azizi F. Khalili S, et al. Sci Rep. 2024 Mar 4;14(1):5244. doi: 10.1038/s41598-024-56061-x. Sci Rep. 2024. PMID: 38438600 Free PMC article.

7

Comparison of Mortality Rate and Severity of Pulmonary Involvement in Coronavirus Disease-2019 Adult Patients With and Without Type 2 Diabetes: A Cohort Study.

Khalili S, Moradi O, Kharazmi AB, Raoufi M, Sistanizad M, Shariat M. Khalili S, et al. Can J Diabetes. 2021 Aug;45(6):524-530. doi: 10.1016/j.jcjd.2020.10.014. Epub 2020 Nov 1. Can J Diabetes. 2021. PMID: 33339741 Free PMC article.

8

Prediction of cardiovascular events with consideration of general and central obesity measures in diabetic adults: results of the 8.4-year follow-up.

Khalili S, Hatami M, Hadaegh F, Sheikholeslami F, Azizi F. Khalili S, et al. Metab Syndr Relat Disord. 2012 Jun;10(3):218-24. doi: 10.1089/met.2011.0070. Epub 2012 Feb 10. Metab Syndr Relat Disord. 2012. PMID: 22324792

9

Independent association between age- and sex-specific metabolic syndrome severity score and cardiovascular disease and mortality.

Honarvar M, Mehran L, Masoumi S, Agahi S, Khalili S, Azizi F, Amouzegar A. Honarvar M, et al. Among authors: khalili s. Sci Rep. 2023 Sep 5;13(1):14621. doi: 10.1038/s41598-023-41546-y. Sci Rep. 2023. PMID: 37669997 Free PMC article.

10

A Phase I Randomized, Double-blind, Placebo-controlled Study on Efficacy and Safety Profile of a Sublingually Administered Cannabidiol /Delta 9-tetrahydrocannabidiol (10: 1) Regimen in Diabetes Type 2 Patients.

Afshar S, Khalili S, Amin G, Abbasinazari M. Afshar S, et al. Among authors: khalili s. Iran J Pharm Res. 2023 Feb 25;21(1):e132647. doi: 10.5812/ijpr-132647. eCollection 2022 Dec. Iran J Pharm Res. 2023. PMID: 36945340 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page